These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1790050)

  • 21. Effects of intervention on compliance to referral and lifestyle recommendations given at cholesterol screening programs.
    Gans KM; Lapane KL; Lasater TM; Carleton RA
    Am J Prev Med; 1994; 10(5):275-82. PubMed ID: 7848670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Women and men with hypercholesterolemia respond similarly to an American Heart Association step 1 diet.
    Geil PB; Anderson JW; Gustafson NJ
    J Am Diet Assoc; 1995 Apr; 95(4):436-41. PubMed ID: 7699185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analytic and clinical performance of two compact cholesterol-testing devices.
    Volles DF; McKenney JM; Miller WG; Ruffen D; Zhang D
    Pharmacotherapy; 1998; 18(1):184-92. PubMed ID: 9469692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A workplace breast cancer screening program. Costs and components.
    Schrammel P; Griffiths RI; Griffiths CB
    AAOHN J; 1998 Nov; 46(11):523-9. PubMed ID: 9934000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood cholesterol screening: influence of fasting state, biological variation and the single cholesterol assay on total cholesterol level.
    Ng TK
    Med J Malaysia; 1993 Mar; 48(1):12-6. PubMed ID: 8341167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone.
    Gail MH; Fears TR; Hoover RN; Chandler DW; Donaldson JL; Hyer MB; Pee D; Ricker WV; Siiteri PK; Stanczyk FZ; Vaught JB; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):835-44. PubMed ID: 8896895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The variability of serum cholesterol measurements: implications for screening and monitoring.
    Thompson SG; Pocock SJ
    J Clin Epidemiol; 1990; 43(8):783-9. PubMed ID: 2384766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-dependent variability in repeated measurements of cholesterol levels: clinical implications for risk misclassification and intervention monitoring.
    Roeback JR; Cook JR; Guess HA; Heyse JF
    J Clin Epidemiol; 1993 Oct; 46(10):1159-71. PubMed ID: 8410100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variations of cholesterol and total lipid concentrations in sera of healthy young men. Differentiating analytic error from biologic variability.
    Statland BE; Winkel P
    Am J Clin Pathol; 1976 Dec; 66(6):935-43. PubMed ID: 998566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with participation in a worksite cholesterol screening and nutrition education program.
    Strychar IM; Shannon B; Sowa DM; Wang MQ
    Am J Health Promot; 1992; 6(4):264-6, 319. PubMed ID: 10146805
    [No Abstract]   [Full Text] [Related]  

  • 31. Cholesterol screening using the school as a worksite.
    Weinberg AD; Iammarino NK; Laufman L; Trost R
    J Sch Health; 1992 Feb; 62(2):45-9. PubMed ID: 1564910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol screening in the workplace.
    Broome J
    Occup Health (Lond); 1990 Mar; 42(3):72-3. PubMed ID: 2325977
    [No Abstract]   [Full Text] [Related]  

  • 33. Variability of total cholesterol concentrations in serum by repeated measurements in a large pediatric population--limitations of quality controls for laboratory analyses.
    Sklov MC; Srinivasan SR; Webber LS; Berenson GS
    Clin Chem; 1981 Dec; 27(12):1988-92. PubMed ID: 7307251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beyond our means: patterns of variability of physiological traits.
    Himmelstein DU; Levins R; Woolhandler S
    Int J Health Serv; 1990; 20(1):115-24. PubMed ID: 2307551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of large-scale cholesterol screening: experience with a portable capillary-blood testing device.
    Greenland P; Levenkron JC; Radley MG; Baggs JG; Manchester RA; Bowley NL
    Am J Public Health; 1987 Jan; 77(1):73-5. PubMed ID: 3789242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Errors in cholesterol determinations.
    SISTER M C ZINGG
    Am J Med Technol; 1951; 17(2):61-4. PubMed ID: 14819027
    [No Abstract]   [Full Text] [Related]  

  • 37. Variability in cholesterol measurements in a worksite cholesterol screening program.
    Stave GM; Winslow BS; Conner GW
    Am J Prev Med; 1991; 7(6):406-9. PubMed ID: 1790050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Logistical implementation of cholesterol screening at the worksite. Appointment versus walk-in approach.
    Nielsen MM
    AAOHN J; 1991 May; 39(5):235-40. PubMed ID: 2025334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precision of a dry-chemistry method of lipid screening.
    Bowden RG; Kingery PM; Long L
    Public Health; 2006 Jun; 120(6):572-6. PubMed ID: 16730036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Variation in serum cholesterol level in the same person: what is the true value and when is it called a significant change?].
    Hendriksen IJ; Bezemer PD; Boerma GJ; Zuiderveld U
    Ned Tijdschr Geneeskd; 1992 Aug; 136(31):1507-11. PubMed ID: 1495568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.